Learn
RARE Daily: the official Global Genes blog
Browse the latest news, articles, and blog posts from Global Genes.
Featured
Enabling On-Demand Therapies
Earlier this year, the company gained attention when it reported that developed a customized antisense oligonucleotide to […]
Read moreAfter Driving an N-of-1 Therapy for Her Son, an Advocate Turns to Helping Others
Yiwei She, founder of the TNPO2 Foundation, discusses how her family was able to treat her son […]
Read morePutting Rare Disease Organization in the Business of Drug Development
Rare disease patient organizations are increasingly driving the discovery and development of therapies to treat the conditions […]
Read moreUnderstanding the Many Questions Gene Therapies Raise
Gene therapies have emerged as an important and growing area of medicine, but various players in the […]
Read moreDrug Development
MDA Launches Program to Develop Gene Therapies for Ultra-Rare Neuromuscular Diseases
Rare Daily Staff The Muscular Dystrophy Association said it has launched the MDA Kickstart program for Ultra-Rare […]
Read moreFDA Grants Full Approval to Travere for Filspari in IgA Nephropathy
Rare Daily Staff The U.S. Food and Drug Administration granted Travere Therapeutics full approval and expanded use […]
Read moreNIMH Awards PsychoGenics $3 million Grant to Use AI Platform for Repurposing
Rare Daily Staff The National Institutes of Health’s National Institute of Mental Health awarded a Fast Track […]
Read moreFDA Grants Accelerated Approval to Gilead’s PBC Drug
Rare Daily Staff The U.S. Food and Drug Administration granted accelerated approval to Gilead Sciences’ Livdelzi for […]
Read moreFDA Approves Ascendis’ Hypoparathyroidism Drug After Delays
Rare Daily Staff The U.S. Food and Drug Administration approved Ascendis’ Yorvipath for the treatment of adults […]
Read moreFDA Approves First Cell Therapy for Solid Tumor
Rare Daily Staff The U.S. Food and Drug Administration granted accelerated approval to Adaptimmune’s Tecelra for a […]
Read moreJames Wilson Departs Penn to Launch to Spin Out Penn Programs into Two New Gene Therapy Companies
Rare Daily Staff Gene therapy pioneer James Wilson is stepping down from his post as director of […]
Read moreFOXG1 Research Foundation Enters Collaboration with CRL to Advance Gene Therapy
Rare Daily Staff The FOXG1 Research Foundation has entered into a collaboration with Charles River Laboratories International […]
Read moreAdvocates Increase Focus on PRV as Deadline to Reauthorize Approaches
Back in February, rare disease organizations applauded the introduction of legislation to reauthorize the Rare Pediatric Priority […]
Read moreFinance
Tern Therapeutics Launches with $15 Million and Pipeline in CLN2 Batten Disease
Rare Daily Staff Tern Therapeutics launched with a $15 million financing and a global licensing agreement with […]
Read moreTaysha Raises $75 Million in Public Offering to Advance Gene Therapy for Rett Syndrome
Rare Daily Staff One week after reporting positive data from phase 1/2 studies of its experimental gene […]
Read moreExsilio Therapeutics Launches with $82 Million to Develop Redosable Genomic Medicines
Rare Daily Staff Exsilio Therapeutics emerged from stealth with $82 million in series A financing to advance […]
Read moreEntrada Raises $100 Million Registered Direct Offering
Rare Daily Staff Entrada Therapeutics entered into a securities purchase agreement with a group of investors in […]
Read moreRare Daily Staff NephroDI Therapeutics raised $2 million from Sound Bioventures that will be used to advance […]
Read moreiOnctura Raises $86 Million to Advance Rare Cancer Pipeline
Rare Daily Staff Swiss biotech iOnctura closed an $86 million (€80 million) series B financing to advance […]
Read moreALS Association Gives ProJenX $1 Million Clinical Trial Award
Rare Daily Staff ProJenX, the biotech created out of a collaboration between Columbia University and Project ALS, […]
Read moreFour Biotechs Raise Almost $1 Billion to Advance Rare Disease Pipelines
Rare Daily Staff Four public companies with a rare disease therapeutics focus tapped the market for almost […]
Read moreFoundation for Fighting Blindness Provides Opus Genetics $1.7 Million in Funding
Rare Daily Staff The Foundation for Fighting Blindness provided $1.7 million in project-based funding to Opus Genetics […]
Read moreMore Stories
Chiesi Global Rare Diseases Launches Grant Initiative to Support Research into LSDs
Rare Daily Staff Chiesi Global Rare Diseases has launched Find For Rare, a new grant initiative to provide […]
Read moreStudy Explores Quality of Life Effects of Healthcare Access on Caregivers
Rare Daily Staff New strategies are needed to better support rare disease caregivers and improve health outcomes […]
Read moreBridgeBio Spins-Out Set of Assets into Newly Formed GondolaBio
Rare Daily Staff BridgeBio said in a filing with the U.S. Securities and Exchange Commission that it […]
Read moreNew Test Uses RNA to Expand Diagnostic Yield of Exome Sequencing
Rare Daily Staff Clinical genomics testing company Ambry Genetics has released ExomeReveal, a new multiomic exome sequencing […]
Read morePatient and Industry Groups Warn New EU Rules Will Reduce New Rare Disease Treatments
Rare Daily Staff New guidelines set to take effect in January in the European Union threaten to […]
Read moreColin Farrell Forms Foundation to Address Needs of Adults with Intellectual Disabilities
Rare Daily Staff Actor Colin Farrell, whose 20-year-old son James has the rare neurological disorder Angelman syndrome, […]
Read moreWhat’s Happening
Caregiver Support Program: Carrie Borrello
In 2024, Global Genes partnered with Brad Thompson, M.A., NCC, LPC-S to host a caregivers support program […]
Read moreFirst Definitive European Clinical Guidelines for BHD Diagnosis & Management
Global Genes asked Global Advocacy Alliance members to share their successes – whether it is meeting an organizational goal, kicking […]
Read moreMaurya’s Rare Odyssey – a RAREly Told Stories film about Hereditary Spastic Paraplegia SPG4
In February of 2024 Global Genes together with The Disorder Channel presented a workshop, RAREly Told Stories, […]
Read moreBeginner’s Guide to Rare Disease, Jessica’s Version
When we asked Jessica Patay for some resources to help guide those just beginning to face a […]
Read moreThe Beginner’s Guide to Rare Disease
If you were just diagnosed with a rare disease or you are feeling you may remain undiagnosed […]
Read moreTBX4 Family Film – A RAREly Told Stories Film
In February of 2024 Global Genes together with The Disorder Channel presented a workshop, RAREly Told Stories, […]
Read moreThe yellow brick road feels a bit different for rare disease families.
There’s No Place Like Hope. There’s No Place Like Hope. You might be right to say we […]
Read moreGlobal Genes’ Sweet 16th Birthday Success Stories
August 15th, 2024 marks Global Genes’ 16th birthday! Since 2008, our organization has made significant efforts and […]
Read moreJansen’s Journey – A RAREly Told Stories film
In February of 2024 Global Genes together with The Disorder Channel presented a workshop, RAREly Told Stories, […]
Read moreReports
Continuing Advocacy and Expanding Research Efforts: Global Genes 2023 Impact Report
To our community members: For both the rare disease community and Global Genes, 2023 marked a year […]
Read moreGlobal Genes 2023 RARE Impact Grants Report
Over the past decade, Global Genes’ RARE Impact Grant Program has provided grants to rare disease patient […]
Read moreNEXT Report 2024: Rewriting the Rules
Over the past year, technological advances in rare disease drug and therapy development, coupled with the tenacity of rare disease patients and advocates, have prevailed despite the challenges of financial difficulties in biopharma. Next-generation patient advocates continue to take an active role in drug development, as outlined in the 2024 NEXT Report.
Read moreMore Resources: Dictionary of Rare Diseases
Search for a specific disease in our extensive list of rare diseases for disease-specific information, news, and resources.
Search Our Full Disease Dictionary